Pipeline-to-Patent Analytics for Life Sciences & Biotech
Optimize R&D capital allocation, control clinical trial economics, accelerate regulatory submissions, and maximize IP portfolio value with AI-powered analytics built for life sciences.
Life Sciences & Biotech Challenges We Solve
Life sciences companies face extraordinary R&D costs, regulatory complexity, and IP management challenges that demand purpose-built financial analytics.
Life Sciences Analytics Solutions
Purpose-built for CSOs, CFOs, and R&D leaders who demand precision in pipeline economics and regulatory intelligence
Key Capabilities:
- Program-level cost allocation
- Phase-gate investment analytics
- ASC 730 capitalization tracking
- Pipeline NPV modeling
Key Capabilities:
- Site-level cost-per-patient analytics
- CRO invoice reconciliation
- Enrollment rate forecasting
- Amendment cost impact modeling
Key Capabilities:
- eCTD module readiness tracking
- Cross-filing gap analysis
- Health authority query analytics
- Submission timeline forecasting
Key Capabilities:
- Real-time patent valuation models
- Licensing deal benchmarking
- Patent cliff impact forecasting
- Freedom-to-operate analytics
Comprehensive Regulatory Coverage
Built-in compliance for FDA regulations, ICH guidelines, and global pharmaceutical reporting requirements
- Audit trail integrity
- Electronic signature validation
- System access controls
- Data integrity verification
- GCP cost compliance monitoring
- ICH Q10 quality system analytics
- Risk-based monitoring economics
- Site inspection readiness
- MAA submission tracking
- Variation management analytics
- Pharmacovigilance cost tracking
- Cross-filing synchronization
- Milestone recognition automation
- Variable consideration tracking
- Collaboration agreement analytics
- Royalty revenue forecasting
Industry-Specific Use Cases
Tailored solutions for different life sciences segments and development stages
Common Challenges:
- • Multi-billion dollar pipeline management
- • Therapeutic area prioritization
- • M&A target valuation
Key Outcomes:
- Portfolio-wide NPV optimization
- Data-driven pipeline prioritization
- AI-powered target due diligence
Common Challenges:
- • Burn rate management with limited capital
- • Investor milestone communication
- • CRO vendor optimization
Key Outcomes:
- Real-time runway forecasting
- Automated investor KPI dashboards
- 25% CRO cost reduction analytics
Common Challenges:
- • Multi-sponsor budget management
- • Resource utilization optimization
- • Change order profitability
Key Outcomes:
- Sponsor-level P&L visibility
- 92% resource utilization targeting
- Change order margin analytics
Common Challenges:
- • 510(k)/PMA submission tracking
- • Post-market surveillance costs
- • Product line profitability
Key Outcomes:
- Automated regulatory pathway tracking
- MDR/IVDR compliance analytics
- SKU-level margin optimization
Life Sciences ERP & Platform Integrations
Pre-built connectors for leading life sciences ERP systems and clinical data platforms
Global Biotech Company
Life Sciences & Biotech • $4.2B Revenue
Challenge
Mid-large biotech company with 14 programs in clinical development across oncology, immunology, and rare disease. R&D spend of $1.8B annually with no program-level cost visibility. Three Phase III trials running 32% over budget. Preparing simultaneous FDA and EMA submissions for lead asset. Patent portfolio of 340+ patents with licensing revenue underperforming by $45M.
Solution
Deployed ZYNOVIQ PROFITGUARD with integration across clinical trial management, R&D finance, and IP management systems. Implemented program-level R&D analytics, real-time trial budget monitoring, regulatory submission tracking, and dynamic IP valuation.
Results Achieved
Ready to Optimize Your Pipeline Economics?
Join leading life sciences and biotech companies who have reduced R&D costs and accelerated time-to-market with ZYNOVIQ PROFITGUARD.